Related Experiment Videos
Molecular typing of IberoAmerican Cryptococcus neoformans isolates
Wieland Meyer1, Alexandra Castañeda, Stuart Jackson
1University of Sydney, Sydney, Australia. w.meyer@usyd.edu.au
Emerging Infectious Diseases
|February 27, 2003
Summary
This study characterized Cryptococcus neoformans isolates from IberoAmerica using molecular typing. The VNI molecular type, associated with human infections, was predominant, highlighting its global significance.
Area of Science:
- Mycology
- Infectious Diseases
- Molecular Biology
Background:
- Cryptococcus neoformans is a significant fungal pathogen.
- Understanding its molecular epidemiology is crucial for public health.
- Previous studies have established molecular types for C. neoformans.
Purpose of the Study:
- To establish a network for basic knowledge acquisition of C. neoformans in IberoAmerican countries.
- To molecularly characterize clinical, veterinary, and environmental isolates of C. neoformans from the region.
- To determine the prevalence of different molecular types within the study population.
Main Methods:
- Utilized M13 polymerase chain reaction (PCR)-fingerprinting for isolate typing.
- Employed orotidine monophosphate pyrophosphorylase (URA5) gene restriction fragment length polymorphism (RFLP) analysis with HhaI and Sau96I double digestion.
- Analyzed 340 isolates from nine IberoAmerican countries and Spain.
Main Results:
- Both typing methods successfully grouped isolates into eight previously defined molecular types.
- The VNI molecular type (var. grubii, serotype A) was the most prevalent, accounting for 68.2% of isolates.
- Other identified types included VNII, VNIII, VNIV, and four genotypes (VGI-VGIV) encompassing var. gatii serotypes B and C.
Conclusions:
- The predominance of the VNI type aligns with its known association with human cryptococcal infections globally.
- The study provides valuable molecular epidemiological data for C. neoformans in the IberoAmerica region.
- This network-based approach facilitates ongoing surveillance and research into C. neoformans.